Compare
Akari Therapeutics vs Sanofi
Akari Therapeutics (AKTX) and Sanofi (SNY) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.
| Akari Therapeutics AKTXNASDAQ · Pharmaceutical Preparations | Sanofi SNYNASDAQ · Pharmaceutical Preparations | |
|---|---|---|
| Insider records, last 12 months | 51 | 0 |
| Congress trades, last 12 months | 0 | 0 |
| Fund positions reported, last 12 months | 0 | 42 |
| Federal contract awards, last 12 months | 0 | 0 |
| Open-market purchases by insiders since 2006 | 31 | 0 |
| Open-market sales by insiders since 2006 | 0 | 0 |
| Last open-market purchase by an insider | Aug 29, 2025 | None on record |
| Next results | Nov 11, 2026 | Not announced |
Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.
Common questions
Which has had more insider buying, Akari Therapeutics or Sanofi?
Since 2006, Akari Therapeutics insiders reported 31 open-market purchases against 0 for Sanofi, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.
Do members of Congress trade AKTX or SNY?
In the last 12 months, members of Congress disclosed 0 trades in Akari Therapeutics (AKTX) and 0 in Sanofi (SNY), each reported as a value range on a periodic transaction report.
When did insiders last buy AKTX and SNY?
Akari Therapeutics: Aug 29, 2025. Sanofi: no open-market purchase on record. Dates are those of the SEC filings.
See the record behind any of these
Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Akari Therapeutics pageSanofi pageRare insider trades this weekAll comparisons
https://oqro.io/compare/aktx-vs-sny